Gastric Cancer Diagnostic Procedure Market Size, Share, and Growth 2023-2028
Gastric Cancer Diagnostic Procedure Market: Strategic Insights
Gastric Cancer Diagnostic Procedure Market
-
CAGR (2022 - 2028)6.5% -
Market Size 2022
US$ 1.31 Billion -
Market Size 2028
US$ 1.91 Billion
Market Dynamics
GROWTH DRIVERS
- Increase in gastric cancer incidence
- Advancements in diagnostic technologies
- Rising demand for early cancer detection
FUTURE TRENDS
- Increased use of non-invasive diagnostic technologies
- Advancements in biomarkers for gastric cancer detection
- Rising interest in personalized diagnostics for cancer treatment
OPPORTUNITIES
- Rising focus on early detection and diagnostics for gastric cancer
- Growing availability of advanced diagnostic technologies
- Increasing adoption of non-invasive diagnostic procedures
Key Players
- Atlas Link Biotech Co Ltd
- Bio Rad Laboratories Inc
- MiRXES Pte Ltd
- Agilent Technologies Inc
- F Hoffmann La Roche Ltd
- bioMerieux SA
- Thermo Fisher Scientific Inc
- Illumina Inc
- Vela Diagnostics Holding Pte Ltd
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Healthcare Provider - Diagnostic Laboratories
- Hospitals
- Cancer Research Institutes
- Oncology Specialty Clinics
Symptom Type - Symptomatic and Asymptomatic
Body Fluid - Blood
- Urine
- Saliva
- Stomach Wash/Gastric Juice
- Tissue
Procedure - Endoscopic Procedures
- Biopsy & Tissue Tests
- Lab Tests
- In-Vitro Diagnostic Tests
- Imaging Tests
- Molecular Diagnostics
- Multiplexing Molecular Diagnostics & Immunoassays
Get Free Sample For